| UltraShape Appoints Ezra Katzen as its General Counsel |
| Mercoledì 02 Maggio 2007 00:00 |
|
Yoqneam, Israel, May 2, 2007 - UltraShape Inc, a global leader in the body contouring market and the first to market a clinically proven, non-invasive body contouring system based on focused ultrasound technology, announced today the appointment of Ezra Katzen as its General Counsel. Katzen will be located at UltraShape's corporate headquarters in Yoqneam, Israel. In addition to taking strategic responsibility for the company’s worldwide legal affairs, Katzen will join UltraShape’s management team and will report to the company’s Chief Executive Officer. "I am pleased to join UltraShape as it strives to grow its leadership position in the industry,” Katzen said. “The potential of working with a first-rate management team and a cutting-edge technology make this an exciting opportunity.” About UltraShapeUltraShape Inc., founded in 2000, is a privately held and venture backed company that develops, manufactures and markets innovative, non-invasive solutions for the aesthetic medical field. The UltraShape expert team is dedicated to the development of cutting-edge body-contouring technology in a mission to enhance patients’ self-image and sense of well-being. The UltraShape CONTOUR I, the first clinically proven non-invasive body contouring solution based on focused ultrasound technology, received the CE Mark in July 2005 and is currently distributed in 45 countries outside the United States. Over 30,000 commercial treatments have been performed to-date.The concept behind the company’s platform technology was developed by Ami Glicksman, M.D., a plastic surgeon and Yoram Eshel, Ph.D., MBA, a medical physicist who teamed up to marry the aesthetic clinical experience of the doctor and the expertise in high power focused ultrasound of the physicist. UltraShape adheres to the highest scientific and quality standards and is ISO 13485:2003 certified. The company has worldwide offices in the United States, Israel, France, United Kingdom, and Italy. The UltraShape CONTOUR Isystem is not cleared by the FDA for marketing in the United States. For more information, please visit www.ultrashape.com. ContactAmanda McNulty SheldonFischer Health +1.310.577.7870 X173 Questo indirizzo e-mail è protetto dallo spam bot. Abilita Javascript per vederlo. Abigail Marks UltraShape +972.4.909.9260 Questo indirizzo e-mail è protetto dallo spam bot. Abilita Javascript per vederlo. Dariela Roffe Porter Novelli +44.207.853.2234 Questo indirizzo e-mail è protetto dallo spam bot. Abilita Javascript per vederlo. |